NCT04950426View on ClinicalTrials.gov

Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

January 13, 2025

Study Completion Date

January 13, 2025

Conditions
Fibromyalgia SyndromePosttraumatic Stress Disorder
Interventions
DRUG

Propranolol

One administration of propranolol, once a week during six weeks. Reading by the participant of his/her traumatic story, 75 minutes (+/- 15 min) after propranolol intake.

Trial Locations (2)

Unknown

Centre Hospitalier Henri Laborit, Poitiers

Centre Hospitalier Nord-Deux-Sèvres, Thouars

All Listed Sponsors
lead

Centre Hospitalier Henri Laborit

OTHER

NCT04950426 - Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome | Biotech Hunter | Biotech Hunter